TherapeuticsMD NASDAQ TXMD
$2.25 0.0000 0.0000%
Today share price
USA
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 22 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

24.08M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

-12.60M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

1.85
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

10.70M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-
Upcoming events TherapeuticsMD All events
No upcoming events scheduled

Stock chart TherapeuticsMD

Stock analysis TherapeuticsMD

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-0.62 -87.57
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
0.69 12.41
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-0.12 -27.42
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
-0.35 0.63
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-139.03 -1.16

Price change TherapeuticsMD per year

0.67$ 2.65$
Min Max

Summary analysis TherapeuticsMD

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure TherapeuticsMD

Revenue and net income TherapeuticsMD

All parameters
Stock news TherapeuticsMD All news

Stocks to Watch: Getty Images, TherapeuticsMD, Solid Biosciences

Stocks to Watch: Getty Images, TherapeuticsMD, Solid Biosciences

TherapeuticsMD to Consider Strategic Alternatives

TherapeuticsMD to Consider Strategic Alternatives

TherapeuticsMD Shares Rise 8.1% on Product License Agreement

TherapeuticsMD Shares Rise 8.1% on Product License Agreement

TherapeuticsMD CEO O'Dowd Steps Down After Less Than a Year

TherapeuticsMD CEO O'Dowd Steps Down After Less Than a Year

TherapeuticsMD Shares Rise 24% After Equity Investment

TherapeuticsMD Shares Rise 24% After Equity Investment

TherapeuticsMD Shares Continue to Slide After Tender Offer Expires

TherapeuticsMD Shares Continue to Slide After Tender Offer Expires

TherapeuticsMD Shares Drop 48% After Tender Offer Expires

TherapeuticsMD Shares Drop 48% After Tender Offer Expires

TherapeuticsMD's stock falls 41% after tender offer expires

TherapeuticsMD Shares Drop 42% After Tender Offer From EW Healthcare Expires

TherapeuticsMD Shares Drop 42% After Tender Offer From EW Healthcare Expires

TherapeuticsMD Shares Soar After Acquisition Agreement

TherapeuticsMD Shares Soar After Acquisition Agreement

TherapeuticsMD to Be Acquired by EW Healthcare Partners >TXMD

About company TherapeuticsMD

TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; and TX-007HR and TX-008HR, which are transdermal patch product candidates. The company's clinical development product is TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription prenatal vitamin and hormone therapy drug products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Address:
951 Yamato Road, Boca Raton, FL, United States, 33431
Company name: TherapeuticsMD
Issuer ticker: TXMD
ISIN: US88338N1072
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2003-12-11
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.therapeuticsmd.com

On which stock exchange are TherapeuticsMD (TXMD) stocks traded?

TherapeuticsMD (TXMD) stocks are traded on NASDAQ.

What is the ticker of TherapeuticsMD stocks (TXMD)?

The stock ticker of TherapeuticsMD’s stocks or in other words, the code is TXMD. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does TherapeuticsMD (TXMD) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, TherapeuticsMD (TXMD) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are TherapeuticsMD (TXMD) stocks traded?

TherapeuticsMD (TXMD) stocks are traded on the NASDAQ exchange in dollars.

What is the price of TherapeuticsMD (TXMD) stocks today?

The current price of TherapeuticsMD stocks on 28.03.2024 is 2.25 dollars. per share.

What is the dynamics of TherapeuticsMD (TXMD) stocks from the beginning of the year?

TherapeuticsMD (TXMD) quotes have increased by -3.43% from the beginning of the year up to 2.25 dollars. per 1 stocks.

How much did TherapeuticsMD (TXMD) stocks increase in марте 2024?

This month TherapeuticsMD (TXMD) quotes have increased by -11.42% to 2.25 dollars. per share.

How much are TherapeuticsMD (TXMD) stocks worth?

Today, on October, 28.03.2024 TherapeuticsMD’s (TXMD) stocks cost 2.25 dollars..

What is the market capitalization of TherapeuticsMD (TXMD)?

Capitalization is the market value of TherapeuticsMD (TXMD) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 28.03.2024, the market capitalization of TherapeuticsMD (TXMD) is estimated at about 24077250 dollars.